DA-5223-R

DRUG2 trials

Sponsors

Dong-A ST Co., Ltd.

Conditions

Healthy Adult

Phase 1

A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects

CompletedNCT07007533

Dong-A ST Co., Ltd.Healthy Adult

Start: 2025-07-04End: 2025-07-17Updated: 2025-08-19

A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

CompletedNCT07633691

Dong-A ST Co., Ltd.Healthy Adult

Start: 2026-06-15End: 2026-07-05Updated: 2026-07-15